Latest post

November is Diabetic Eye Disease Awareness Month

This November, in support of Diabetic Eye Disease Awareness Month, Oxurion is partnering with Prevent Blindness and its sight saving efforts.

back of the eye diseases, science community

“We need therapies fighting different hallmarks simultaneously”

PDR and DME are two manifestations of diabetic retinopathy (DR), and in many respects they stem from the same cause, explains Prof. Alan Stitt, Dean of Innovation & Impact and ...

back of the eye diseases, science community

“Developing novel drugs through collaboration and strong science”

“We work as a complimentary team, putting Oxurion in a unique position as a very agile biotech company,” says Susan Schneider, who joined the company’s leadership team in 2017 ...

back of the eye diseases

“JETREA has a group of very loyal users worldwide”

Vinciane Vangeersdaele joined the Oxurion leadership team this past year. With extensive experience in commercializing pharmaceutical portfolios worldwide, including in ...